Pointwise Methods to Measure Long-term Visual Field Progression in Glaucoma
- PMID: 32239185
- PMCID: PMC7118669
- DOI: 10.1001/jamaophthalmol.2020.0647
Pointwise Methods to Measure Long-term Visual Field Progression in Glaucoma
Abstract
Importance: Rates of visual field (VF) progression vary among patients with glaucoma. Knowing the rate of progression of individual patients would allow appropriately aggressive therapy for patients with high rates of visual loss and protect those with low rates from unnecessary therapy.
Objective: To compare 3 pointwise methods of estimating the rate of VF progression in glaucoma.
Design, setting, and participants: This retrospective, observational cohort study included 729 eyes of 567 consecutive patients with primary open-angle glaucoma who had at least 6 reliable VFs and at least 3 years of follow-up. One hundred seventy-six patients (257 eyes) were treated at a tertiary glaucoma center; in addition, data were collected from 391 participants (472 eyes) in the Advanced Glaucoma Intervention Study. Data were collected from May 1988 to November 2004 and analyzed from October 2018 to February 2019.
Exposures: Estimates of VF progression were measured with guided progression analysis (GPA), pointwise linear regression (PLR), and the glaucoma rate index (GRI). A subgroup analysis was performed in a subset of patients with likely VF progression and likely VF stability.
Main outcomes and measures: Proportion of VF series detected as progressing, estimates of false-positive proportions, time to detect progression, and agreement among measures.
Results: Among the 567 patients included in the analysis, mean (SD) age was 65.6 (9.7) years, 300 (52.9%) were female, and 295 (52.0%) were white. The median baseline mean deviation was -6.7 (interquartile range [IQR], -11.6 to -3.5) dB; the median follow-up time, 8.9 (IQR, 7.3-10.4) years. The proportion of eyes labeled as progressing was 27.7% according to the GPA, 33.5% according to the PLR, and 52.9% according to the GRI; pairwise differences for GRI vs PLR were 20% (95% CI, 17%-23%); for GRI vs GPA, 25% (95% CI, 22%-29%); and for PLR vs GPA, 6% (95% CI, 3%-9%; P < .001 for all comparisons, McNemar test). The shortest median time to progression was with the GRI (8.8 [IQR, 2.4-10.5 years), compared with the GPA and PLR (both >16 years). The hazard ratio of VF progression for GRI vs PLR (reference) was 11.3 (95% CI, 9.2-13.7); for GRI vs GPA (reference), 18.1 (95% CI, 14.5-22.6); and for PLR vs GPA (reference), 1.5 (95% CI, 1.3-1.9; P < .001 for all comparisons, Cox proportional hazards regression). These results held in the subgroup with likely progression; the proportions of progressing eyes were 73.7% (115 of 156) for GPA, 81.4% (127 of 156) for PLR, and 92.9% (145 of 156) for GRI. Pairwise difference for GRI vs PLR was 11.5% (95% CI, 7.4%-17.6%; P < .001, McNemar test); for GRI vs GPA, 19.2% (95% CI, 12.6%-26.4%; P < .001, McNemar test); and for PLR vs GPA, 7.7% (95% CI, 0.3%-15.7%; P = .08, McNemar test).
Conclusions and relevance: These results suggest GRI can detect long-term VF progression in glaucoma earlier than PLR or GPA. Validation with prospective designs may strengthen the generalizability and value of this method.
Conflict of interest statement
Figures
Similar articles
-
Risk of Visual Field Progression in Glaucoma Patients with Progressive Retinal Nerve Fiber Layer Thinning: A 5-Year Prospective Study.Ophthalmology. 2016 Jun;123(6):1201-10. doi: 10.1016/j.ophtha.2016.02.017. Epub 2016 Mar 19. Ophthalmology. 2016. PMID: 27001534
-
Cataract Surgery and Rate of Visual Field Progression in Primary Open-Angle Glaucoma.Am J Ophthalmol. 2019 May;201:19-30. doi: 10.1016/j.ajo.2019.01.019. Epub 2019 Jan 28. Am J Ophthalmol. 2019. PMID: 30703355
-
Rate of visual field decay in glaucomatous eyes with acquired pits of the optic nerve.Br J Ophthalmol. 2021 Mar;105(3):381-386. doi: 10.1136/bjophthalmol-2020-315980. Epub 2020 May 13. Br J Ophthalmol. 2021. PMID: 32404356
-
Early Detection of Glaucomatous Visual Field Progression Using Pointwise Linear Regression With Binomial Test in the Central 10 Degrees.Am J Ophthalmol. 2019 Mar;199:140-149. doi: 10.1016/j.ajo.2018.11.004. Epub 2018 Nov 20. Am J Ophthalmol. 2019. PMID: 30465746
-
Central visual field in glaucoma: An updated review.Taiwan J Ophthalmol. 2024 Sep 13;14(3):360-370. doi: 10.4103/tjo.TJO-D-24-00042. eCollection 2024 Jul-Sep. Taiwan J Ophthalmol. 2024. PMID: 39430344 Free PMC article. Review.
Cited by
-
Long-term prognosis of acute primary angle closure in an east asian cohort.Jpn J Ophthalmol. 2024 Jul;68(4):302-310. doi: 10.1007/s10384-024-01065-3. Epub 2024 May 13. Jpn J Ophthalmol. 2024. PMID: 38739252 Free PMC article.
-
Pointwise and Region-Wise Course of Visual Field Loss in Patients With Glaucoma.Transl Vis Sci Technol. 2022 Jul 8;11(7):20. doi: 10.1167/tvst.11.7.20. Transl Vis Sci Technol. 2022. PMID: 35877094 Free PMC article.
References
-
- Bourne RRA, Taylor HR, Flaxman SR, et al. ; Vision Loss Expert Group of the Global Burden of Disease Study . Number of people blind or visually impaired by glaucoma worldwide and in world regions 1990-2010: a meta-analysis. PLoS One. 2016;11(10):e0162229. doi:10.1371/journal.pone.0162229 - DOI - PMC - PubMed
-
- Musch DC, Gillespie BW, Lichter PR, Niziol LM, Janz NK; CIGTS Study Investigators . Visual field progression in the Collaborative Initial Glaucoma Treatment Study: the impact of treatment and other baseline factors. Ophthalmology. 2009;116(2):200-207. doi:10.1016/j.ophtha.2008.08.051 - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
